GLP-Talk • Answers & Community
It is common to see forum discussions about a weight-loss plateau on semaglutide or tirzepatide. A plateau is not automatically evidence that medication has stopped working.
Weight change is rarely a straight line. A plateau describes a period when measured weight changes little, but the timing and explanation vary. Review the trend and broader health picture with your clinician rather than making unsupervised medication changes.
What counts as a plateau?
A plateau is generally a sustained period with little or no downward change in measured weight. Day-to-day numbers can vary for reasons including hydration, meal timing, exercise and normal body fluctuations.
There is no universal calendar threshold that proves a medication has failed. Look at the longer-term trend and the goal established with your healthcare team.
Why might weight change slow over time?
As weight changes, energy needs and activity patterns may change, and the initial rate of weight loss may not continue indefinitely. Sleep, nutrition, other medications, medical conditions, stress and consistency with a care plan can all influence progress.
NIDDK explains that weight-management medicines are most effective alongside long-term lifestyle support, and progress depends on the individual, health conditions and the medicine involved.
How can progress be considered beyond the scale?
- Clinician-guided glucose or cardiometabolic measures where appropriate.
- Functional goals, physical activity, strength and daily routines.
- Dietary adequacy and wellbeing rather than restrictive comparisons.
- Sustainable behaviors, adherence to prescribed care and tolerance.
- Longer-term results rather than isolated daily measurements.
What should you discuss at follow-up?
Discuss your original treatment goals, any side effects, sleep and nutrition patterns, other medications, and how progress is measured. A prescriber can determine whether a change in the care plan, further evaluation, or a different approach is warranted.
Do not use advice from strangers to increase, combine, skip or stop doses. Product-specific directions and safety considerations matter.
How does research describe response?
Clinical studies measure outcomes over defined periods and often report averages for groups of participants. A result in a trial is not a promise for any one individual. The apparent size of a benefit can also depend on the comparator group and the study’s follow-up time.
To compare studies carefully, check enrollment criteria, baseline weight, discontinuation rates, adverse events, and whether participants were receiving structured lifestyle support.
What makes a helpful discussion thread?
Explain whether you’re talking about your own general experience, scientific research or a question for your clinician. Avoid comparisons that shame people for individual results or encourage unsafe methods. Ask others what information helped them have constructive follow-up appointments.
Members can share observations about routine, motivation and uncertainty; treatment changes need professional guidance.
Questions people frequently ask
Does a plateau mean a GLP-1 medicine no longer works?
Not necessarily. Changes in weight over time do not, by themselves, identify the cause or determine whether treatment remains appropriate.
Should I increase my dose when progress slows?
Only a qualified prescriber can assess medication changes for an individual.
Can a plateau happen with both semaglutide and tirzepatide?
Yes, individuals taking different medications may experience periods when weight change slows or stops.
Are forum results a reliable prediction of mine?
No. Personal stories are helpful context but do not replace controlled evidence or individualized clinical care.
Ask the GLP-Talk community
Discuss sustainable routines, expectations and follow-up questions without comparing or prescribing medication doses.
Browse related discussions →Explore related questions
Sources and further reading
Medical safety: Descriptions of other members’ experiences do not replace a licensed clinician’s evaluation. Severe or worsening symptoms need prompt medical attention. Verify drug approval and labeling using official sources.